EPS for Evolent Health (EVH) Expected At $-0.09; Horizon Technology Finance (HRZN)’s Sentiment Is 1.44

October 27, 2017 - By Marguerite Chambers

Analysts expect Evolent Health Inc (NYSE:EVH) to report $-0.09 EPS on November, 8.They anticipate $0.17 EPS change or 65.38% from last quarter’s $-0.26 EPS. After having $-0.13 EPS previously, Evolent Health Inc’s analysts see -30.77% EPS growth. The stock decreased 1.34% or $0.23 during the last trading session, reaching $16.6. About 936,883 shares traded. Evolent Health Inc (NYSE:EVH) has risen 80.60% since October 27, 2016 and is uptrending. It has outperformed by 63.90% the S&P500.

Horizon Technology Finance Corporation is an externally managed, closed-end, non-diversified management investment company. The company has market cap of $122.69 million. The Company’s investment objective is to maximize investment portfolio’s total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It currently has negative earnings. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services and cleantech industries .

Evolent Health, Inc. is engaged in healthcare delivery and payment. The company has market cap of $1.28 billion. The Firm supports health systems and physician organizations in their migration toward value care and population health management. It currently has negative earnings. The Firm provides an end-to-end, technology-enabled services platform for providers.

Among 14 analysts covering Evolent Health (NYSE:EVH), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health had 28 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by FBR Capital on Friday, August 5 with “Outperform”. On Monday, March 14 the stock rating was maintained by JP Morgan with “Overweight”. Jefferies initiated Evolent Health Inc (NYSE:EVH) on Tuesday, July 26 with “Buy” rating. On Wednesday, August 9 the stock rating was maintained by Cantor Fitzgerald with “Buy”. As per Tuesday, March 29, the company rating was initiated by FBR Capital. The stock of Evolent Health Inc (NYSE:EVH) has “Buy” rating given on Wednesday, January 6 by Canaccord Genuity. The firm has “Overweight” rating by JP Morgan given on Friday, October 28. The stock has “Buy” rating by Canaccord Genuity on Tuesday, August 8. On Sunday, September 24 the stock rating was maintained by Robert W. Baird with “Buy”. The stock of Evolent Health Inc (NYSE:EVH) earned “Buy” rating by Robert W. Baird on Wednesday, June 14.

The stock increased 0.38% or $0.04 on October 27, reaching $10.65. About 20,619 shares traded. Horizon Technology Finance Corp (HRZN) has declined 4.01% since October 27, 2016 and is downtrending. It has underperformed by 20.71% the S&P500.

Analysts await Horizon Technology Finance Corp (NASDAQ:HRZN) to report earnings on November, 7. They expect $0.29 EPS, down 23.68% or $0.09 from last year’s $0.38 per share. HRZN’s profit will be $3.34M for 9.18 P/E if the $0.29 EPS becomes a reality. After $0.24 actual EPS reported by Horizon Technology Finance Corp for the previous quarter, Wall Street now forecasts 20.83% EPS growth.